Obesity and hypertension interact to increase risk of renal cell carcinoma in Iowa, USA

Obesity Research and Clinical Practice

Volumn 1, Issue 2, 2007, Pages 147-153

  Brock, Kaye E ^a   Gridley, Gloria ^b   Lynch, Charles F ^c   Ershow, Abby G ^d   Cantor, Kenneth P ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Hypertension; Interaction effect modification; Kidney epidemiology; Obesity; Renal cell carcinoma

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

EID: 34247473107     PISSN: 1871403X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orcp.2007.02.004     Document Type: Article

References (52)

1. Moore L.E., Wilson R.T., and Campleman S.L. Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 23 (2005) 240-255
2. Devesa S.S., Silverman D.T., McLaughlin J.K., Brown C.C., Connelly R.R., and Fraumeni Jr. J.F. Comparison of the descriptive epidemiology of urinary tract cancers. Cancer Causes Control 1 (1990) 133-141
3. Flegal K.M. The obesity epidemic in children and adults: current evidence and research issues. Med Sci Sports Exerc 31 11 Suppl. (1999) S509-S514
4. Fields L.E., Burt V.L., Cutler J.A., Hughes J., Roccella E.J., and Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44 (2004) 398-404
5. Bergstrom A., Hsieh C.C., Lindblad P., Lu C.M., Cook N.R., and Wolk A. Obesity and renal cell cancer-a quantitative review. Br J Cancer 85 (2001) 984-990
6. Grossman E., Messerli F.H., Boyko V., and Goldbourt U. Is there an association between hypertension and cancer mortality?. Am J Med 112 (2002) 479-486
7. Maclure M., and Willett W. A case-control study of diet and risk of renal adenocarcinoma. Epidemiology 1 (1990) 430-440
8. Muscat J.E., Hoffmann D., and Wynder E.L. The epidemiology of renal cell carcinoma. A second look. Cancer 75 (1995) 2552-2557
9. Chow W.H., Gridley G., Fraumeni Jr. J.F., and Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343 (2000) 1305-1311
10. Cantor K.P., Lynch C.F., and Johnson D. Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 4 (1993) 505-511
11. Chiu B.C., Gapstur S.M., Chow W.H., Kirby K.A., Lynch C.F., and Cantor K.P. Body mass index, physical activity, and risk of renal cell carcinoma. Int J Obes 30 (2006) 940-947
12. Hartge P., Brinton L.A., Rosenthal J.F., Cahill J.I., Hoover R.N., and Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol 120 (1984) 825-833
13. Lynch C.F., Logsden-Sackett N., Edwards S.L., and Cantor K.P. The driver's license list as a population-based sampling frame in Iowa. Am J Public Health 84 (1994) 469-472
14. Guidelines on Overweight and Obesity:Electronic Textbook, NHLBI, NIH, 1998. http://www.nhlbi.nih.gov/guidelines/obesity/e_txtbk/index.htm.
15. Breslow NE, Day NE. Statistical methods in Cancer Research International Agency for Research on Cancer Lyon printed in Switzerland, 1980.
16. Flegal K.M., Carroll M.D., Juczmarski R.J., and Johnson C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22 (1998) 39-47
17. Samanic C., Chow W.H., Gridley G., Jarvholm B., and Fraumeni Jr. J.F. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17 (2006) 901-909
18. Schouten L.J., van Dijk B.A., Oosterwijk E., Hulsbergen-van de Kaa C.A., Kiemeney L.A., Goldbohm R.A., et al. Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study. J Hypertens 23 (2005) 1997-2004
19. Oh E.W., Yoon Y.S., and Shin S.A. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 23 21 (2005) 4742-4754
20. Hjartaker A., Adami H.O., Lund E., and Weiderpass E. Body mass index and mortality in a prospectively studied cohort of Scandinavian women: the women's lifestyle and health cohort study. Eur J Epidemiol 20 (2005) 747-754
21. Lindgren A.M., Nissinen A.M., Tuomilehto J.O., and Pukkala E. Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens 19 (2005) 373-379
22. Pischon T., Lahmann P.H., Boeing H., Tjonneland A., Halkjaer J., and Overvad K. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118 (2006) 728-738
23. Bjorge T., Tretli S., and Engeland A. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. Br J Cancer 93 (2005) 807-810
24. Van Dijk B.A., Schouten L.J., Kiemeney L.A., Goldbohm R.A., and van den Brandt P.A. Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study. Am J Epidemiol 160 (2004) 1159-1167
25. Nicodemus K.K., Sweeney C., and Folsom A.R. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer 108 (2004) 115-121
26. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
27. Hu J., Mao Y., and White K. Overweight and obesity in adults and risk of renal cell carcinoma in Canada. Soz Praventivmed 48 (2003) 178-185
28. Tulinius H., Sigfusson N., Sigvaldason H., Bjarnadottir K., and Tryggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6 (1997) 863-873
29. Choi M.Y., Jee S.H., Sull J.W., and Nam C.M. The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int 67 (2005) 647-652
30. Washio M., Mori M., Sakauchi F., Watanabe Y., Ozasa K., Hayashi K., et al. Risk factors for kidney cancer in a Japanese population: findings from the JACC Study. J Epidemiol 15 Suppl. 2 (2005) S203-S211
31. Coughlin S.S., Neaton J.D., Randall B., and Sengupta A. Predictors of mortality from kidney cancer in 332,547 men screened for the Multiple Risk Factor Intervention Trial. Cancer 79 (1997) 2171-2177
32. Flaherty K.T., Fuchs C.S., Colditz G.A., Stampfer M.J., Speizer F.E., Willett W.C., et al. A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control 16 (2005) 1099-1106
33. Kean W.F., Kasiske B.L., O'Donnell M.P., and Kim Y. Hypertension, hyperlipidemia and renal damage. Am J Kidney Dis 21 Suppl (1993) 43-50
34. Moyad M.A. Obesity, interrelated mechanisms, and exposures and kidney cancer seminars. Urol Oncol 19 4 (2001) 270-279
35. Gago-Dominguez M., Castelao J.E., Yuan J.M., Ross R.K., and Yu M.C. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 13 (2002) 287-293
36. Gago-Dominguez M., and Castelao J.E. Lipid peroxidation and renal cell carcinoma: further supportive evidence and new mechanistic insights. Free Radic Biol Med 40 (2006) 721-733
37. Olusi S.O. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 26 (2002) 1159-1164
38. Keidar S., Kaplan M., Shapira C., Brook J.G., and Aviram M. Low density lipoprotein isolated from patients with essential hypertension exhibits increase propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis 107 (1994) 71-84
39. Dobrian A.D., Davies M.J., Prewitt R.L., and Lauterio T.J. Development of hypertension in a rat model of diet-induced obesity. Hypertension 27 (2001) 309-316
40. Wang M.Y., and Liehr J.G. Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis 16 (1995) 1941-1945
41. Lui M., and Okada S. Induction of free radicals and tumors in the kidneys of Wistar rats by ferric ethylenediamine-N,N′-diacetate. Carcinogenesis 15 (1994) 2817-2821
42. Moore K. Cytochrome P450 products and renal function in cirrhosis: the HETE is on. Hepatology 27 (1998) 1166-1168
43. Usyal M., Bulur H., and Sener D. Lipid peroxidation in patients with essential hypertension. Int J Clin Pharmacol Ther Toxicol 24 (1986) 474-476
44. Okamoto A., Asai A., Saito H., Okabe M., and Gomi K. Differential effect of duocarmycin A and its novel derivative DU-86 on DNA strand breaks in HeLa S3 cells. Jpn J Cancer Res 85 (1994) 1304-1311
45. SEER State Cancer Profiles, NCI http://statecancerprofiles.cancer.gov/.
46. Nelson D.E., Powell-Griner E., Town M., and Kovar M.G. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health 93 (2003) 1335-1341
47. Mack A.K., and Ahluwalia I.B. Monitoring women's health in the U.S.: selected chronic disease indicators, 1991-2001 BRFSS. J Women Health 12 (2003) 309-314
48. Paffenbarger Jr. R.S., Wing A.L., and Hyde R.T. Physical activity as an index of heart attack risk in college alumni. 1978. Am J Epidemiol 142 (1995) 889-903
49. Fryzek J.P., Poulsen A.H., Johnsen S.P., McLaughlin J.K., Sorensen H.T., and Friis S. A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer 92 (2005) 1302-1306
50. Shapiro J.A., Williams M.A., Weiss N.S., Stergachis A., LaCroix A.Z., and Barlow W.E. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol 149 (1999) 521-530
51. Yuan J.M., Castelao J.E., Gago-Dominguez M., Ross R.K., and Yu M.C. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 77 (1998) 1508-1513
52. Pukkala E., Kaprio J., Koskenvuo M., Kujala U., and Sarna S. Cancer incidence among Finnish world class male athletes. Int J Sports Med 21 (2000) 216-220